Mutation of juxtamembrane cysteines in the tetraspanin CD81 affects palmitoylation and alters interaction with other proteins at the cell surface

Experimental Cell Research

Volumn 315, Issue 11, 2009, Pages 1953-1963

  Delandre, Caroline ^a   Penabaz, Taryn R ^a   Passarelli, A Lorena ^a   Chapes, Stephen K ^a   Clem, Rollie J ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

CD81; CD9; EWI 2; Palmitoylation; Proteolysis; Tetraspanin

Indexed keywords

CD81 ANTIGEN; CD9 ANTIGEN; CYSTEINE; MEMBRANE PROTEIN; MUTANT PROTEIN; TETRASPANIN;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TRANSPORT;

EID: 67349207886     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.03.013     Document Type: Article

References (33)

1. Hemler M.E. Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 6 (2005) 801-811
2. Levy S., and Shoham T. The tetraspanin web modulates immune-signaling complexes. Nat. Rev. Immunol. 5 (2005) 136-148
3. Oren R., Takahashi S., Doss C., Levy R., and Levy S. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10 (1990) 4007-4015
4. Bradbury L.E., Kansas G.S., Levy S., Evans R.L., and Tedder T.F. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149 (1992) 2841-2850
5. Horvath G., Serru V., Clay D., Billard M., Boucheix C., and Rubinstein E. CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82,. J. Biol. Chem. 273 (1998) 30537-30543
6. Shoham T., Rajapaksa R., Kuo C.C., Haimovich J., and Levy S. Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments. Mol. Cell Biol. 26 (2006) 1373-1385
7. Cherukuri A., Shoham T., Sohn H.W., Levy S., Brooks S., Carter R., and Pierce S.K. The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts. J. Immunol. 172 (2004) 370-380
8. Maecker H.T., and Levy S. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J. Exp. Med. 185 (1997) 1505-1510
9. Miyazaki T., Muller U., and Campbell K.S. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J. 16 (1997) 4217-4225
10. Tsitsikov E.N., Gutierrez-Ramos J.C., and Geha R.S. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10844-10849
11. Maecker H.T., Do M.S., and Levy S. CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2458-2462
12. Deng J., Yeung V.P., Tsitoura D., DeKruyff R.H., Umetsu D.T., and Levy S. Allergen-induced airway hyperreactivity is diminished in CD81-deficient mice. J. Immunol. 165 (2000) 5054-5061
13. Imai T., and Yoshie O. C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J. Immunol. 151 (1993) 6470-6481
14. Imai T., Kakizaki M., Nishimura M., and Yoshie O. Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82. J. Immunol. 155 (1995) 1229-1239
15. Witherden D.A., Boismenu R., and Havran W.L. CD81 and CD28 costimulate T cells through distinct pathways. J. Immunol. 165 (2000) 1902-1909
16. Mittelbrunn M., Yanez-Mo M., Sancho D., Ursa A., and Sanchez-Madrid F. Cutting edge: dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC. J. Immunol. 169 (2002) 6691-6695
17. Linder M.E., and Deschenes R.J. New insights into the mechanisms of protein palmitoylation. Biochemistry 42 (2003) 4311-4320
18. Resh M.D. Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci. STKE (2006) re14 DOI: 10.1126/stke.3592006re14
19. Charrin S., Manie S., Oualid M., Billard M., Boucheix C., and Rubinstein E. Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation. FEBS Lett. 516 (2002) 139-144
20. Yang X., Claas C., Kraeft S.K., Chen L.B., Wang Z., Kreidberg J.A., and Hemler M.E. Palmitoylation of tetraspanin proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology. Mol. Biol. Cell 13 (2002) 767-781
21. Berditchevski F., Odintsova E., Sawada S., and Gilbert E. Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling. J. Biol. Chem. 277 (2002) 36991-37000
22. Zhou B., Liu L., Reddivari M., and Zhang X.A. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Cancer Res. 64 (2004) 7455-7463
23. Clark K.L., Oelke A., Johnson M.E., Eilert K.D., Simpson P.C., and Todd S.C. CD81 associates with 14-3-3 in a redox-regulated palmitoylation-dependent manner. J. Biol. Chem. 279 (2004) 19401-19406
24. Cherukuri A., Carter R.H., Brooks S., Bornmann W., Finn R., Dowd C.S., and Pierce S.K. B cell signaling is regulated by induced palmitoylation of CD81. J. Biol. Chem. 279 (2004) 31973-31982
25. Seigneuret M. Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily. Biophys. J. 90 (2006) 212-227
26. Silvie O., Charrin S., Billard M., Franetich J.F., Clark K.L., van Gemert G.J., Saurwein R.W., Dautry F., Boucheix C., Mazier D., and Rubinstein E. Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites. J. Cell Sci. 119 (2006) 1992-2002
27. Bertaux C., and Dragic T. Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry. J. Virol. 80 (2006) 4940-4948
28. Percherancier Y., Planchenault T., Valenzuela-Fernandez A., Virelizier J.L., Arenzana-Seisdedos F., and Bachelerie F. Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor. J. Biol. Chem. 276 (2001) 31936-31944
29. Petaja-Repo U.E., Hogue M., Leskela T.T., Markkanen P.M., Tuusa J.T., and Bouvier M. Distinct subcellular localization for constitutive and agonist-modulated palmitoylation of the human delta opioid receptor. J. Biol. Chem. 281 (2006) 15780-15789
30. Tanaka K., Nagayama Y., Nishihara E., Namba H., Yamashita S., and Niwa M. Palmitoylation of human thyrotropin receptor: slower intracellular trafficking of the palmitoylation-defective mutant. Endocrinology 139 (1998) 803-806
31. Fukushima Y., Saitoh T., Anai M., Ogihara T., Inukai K., Funaki M., Sakoda H., Onishi Y., Ono H., Fujishiro M., Ishikawa T., Takata K., Nagai R., Omata M., and Asano T. Palmitoylation of the canine histamine H2 receptor occurs at Cys(305) and is important for cell surface targeting. Biochim. Biophys. Acta 1539 (2001) 181-191
32. Abache T., Le Naour F., Planchon S., Harper F., Boucheix C., and Rubinstein E. The transferrin receptor and the tetraspanin web molecules CD9, CD81, and CD9P-1 are differentially sorted into exosomes after TPA treatment of K562 cells. J. Cell Biochem. 102 (2007) 650-664
33. Komada Y., and Sakurai M. Shedding of CD9 antigen in acute lymphoblastic leukemia. Leuk. Lymphoma 12 (1994) 365-372